Free Trial

EULAV Asset Management Decreases Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy logo with Medical background

EULAV Asset Management trimmed its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 42.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,700 shares of the company's stock after selling 31,900 shares during the quarter. EULAV Asset Management owned about 0.29% of U.S. Physical Therapy worth $3,698,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Canada Pension Plan Investment Board acquired a new stake in U.S. Physical Therapy during the second quarter worth $28,000. Innealta Capital LLC acquired a new position in shares of U.S. Physical Therapy in the second quarter valued at approximately $30,000. Quest Partners LLC grew its stake in shares of U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company's stock worth $32,000 after acquiring an additional 337 shares in the last quarter. Quarry LP boosted its stake in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company's stock worth $48,000 after buying an additional 478 shares during the last quarter. Finally, Ridgewood Investments LLC acquired a new position in U.S. Physical Therapy during the second quarter worth $51,000.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH traded up $3.54 during mid-day trading on Wednesday, hitting $94.17. The company had a trading volume of 224,928 shares, compared to its average volume of 92,797. The stock's 50-day moving average price is $84.68 and its 200-day moving average price is $90.85. The company has a market capitalization of $1.42 billion, a price-to-earnings ratio of 100.18, a P/E/G ratio of 4.07 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be given a dividend of $0.44 per share. The ex-dividend date is Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.87%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 187.23%.

Insider Activity

In other news, Director Nancy Ham sold 1,172 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.72, for a total value of $113,355.84. Following the transaction, the director now owns 1,112 shares in the company, valued at approximately $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction on Tuesday, September 3rd. The shares were bought at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the purchase, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 11.83 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 6,896 shares of company stock valued at $656,940. Corporate insiders own 1.70% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on USPH. Bank of America reaffirmed a "neutral" rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research reiterated an "outperform" rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 7th. Finally, StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st.

Check Out Our Latest Stock Analysis on USPH

U.S. Physical Therapy Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Articles

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

→ Trump won. Buy this coin now. (From Weiss Ratings) (Ad)

Should you invest $1,000 in U.S. Physical Therapy right now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines